Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | Fund Letter | Christopher GodfreyHeadwaters Capital | Bio-Techne $TECH• NASDAQ | BiotechnologyBiotechnology | Headwaters Capital 2025 Q2 (TECH) Bio-Techne: Coveted Life Sciences Asset On Sale Due to Academic Pressures Summary Thesis: 1) Market leading life sciences reagents and instrument company. Recurring consumable revenue,... | BULL | View Pitch → |
| Dec 3, 2025 | Fund Letter | Amy ZhangAlger Small Cap Focus Fund | Bio-Techne $TECH• NASDAQ | BiotechnologyBiotechnology | Alger Small Cap Focus Fund 2025 Q2 (TECH) Bio-Techne is a leading provider of essential life science products, including reagents (such as proteins), analytical instruments, and related services. Its products are... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.